Drugs / Ganoderma spore oil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07554885 | Apr 2026 → Dec 2028 expected | drug or radiation exposure-related interstitial lung disease, neoplasm | Guangzhou Institute of Respiratory Disease | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ganoderma spore oil | “Ganoderma spore oil” NCT07554885 ↗ |
| Route | Oral | “800 mg orally twice daily” NCT07554885 ↗ |